表紙
市場調查報告書
商品編碼
1063094

獸醫用照護現場診斷的全球市場(2022年∼2029年)

Global Veterinary Point-Of-Care Diagnostics Market - 2022-2029

出版日期: | 出版商: DataM Intelligence | 英文 160 Pages | 商品交期: 約2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

  • 全貌
  • 簡介
  • 目錄
簡介

本報告提供全球獸醫用照護現場診斷市場相關調查分析,提供市場動態,產業分析,市場分析,競爭情形等系統性資訊。

目錄

第1章 全球獸醫用照護現場診斷市場調查手法和範圍

  • 調查手法
  • 調查的目的和調查範圍

第2章 全球獸醫用照護現場診斷市場-市場定義和概要

第3章 全球獸醫用照護現場診斷-摘要整理

  • 市場明細:各產品
  • 市場明細:應用
  • 市場明細:各終端用戶
  • 市場明細:各地區

第4章 全球獸醫用照護現場診斷市場-市場動態

  • 影響市場的要素
    • 促進因素
    • 阻礙因素
    • 市場機會
    • 影響分析

第5章 全球獸醫用照護現場診斷市場-產業分析

  • 波特的五力分析
  • 供應鏈分析
  • 價格分析
  • 法規分析
  • 未滿足需求

第6章 全球獸醫用照護現場診斷市場-COVID-19分析

  • 市場COVID-19分析
    • COVID-19前的市場方案
    • 目前COVID-19市場方案
    • COVID-19後的市場方案/未來市場方案
  • COVID-19的價格的動態
  • 需求與供給的頻譜
  • 政府在COVID-19疫情下的市場相關措施
  • 製造商策略性舉措
  • 結論

第7章 全球獸醫用照護現場診斷市場:各產品

  • 簡介
  • 市場規模分析,及與前一年同期比較成長分析(%):各產品
  • 市場魅力指數:各產品
    • 消耗品,試劑,及套件
    • 設備和設備

第8章 全球獸醫用照護現場診斷市場:各應用領域

  • 簡介
  • 市場規模分析,及與前一年同期比較成長分析(%):各應用領域
  • 市場魅力指數:各應用領域
    • 寄生蟲診斷
    • 影像診斷
    • 細菌診斷
    • 病毒診斷
    • 細胞診斷
    • 臨床化學診斷
    • 血清診斷
    • 其他

第9章 全球獸醫用照護現場診斷:各終端用戶

  • 簡介
    • 市場規模分析,及與前一年同期比較成長分析(%):各終端用戶
    • 市場魅力指數:各終端用戶
  • 動物醫院及診所*
    • 簡介
    • 市場規模分析,100萬美元(2020年∼2029年),及與前一年同期比較成長分析(%)(2021年∼2029年)
  • 居家醫療
  • 其他

第10章 全球獸醫用照護現場診斷:各地區

  • 簡介
    • 市場規模分析,100萬美元(2020年∼2029年),及與前一年同期比較成長分析(%)(2021年∼2029年):各地區
    • 市場魅力指數:各地區
  • 北美
  • 歐洲
  • 南美
  • 亞太地區
  • 中東和非洲

第11章 全球獸醫用照護現場診斷市場-競爭情形

  • 主要的開發與策略
  • 企業佔有率分析
  • 產品的基準

第12章 全球獸醫用照護現場診斷市場-企業簡介概要

  • Heska Corporation*
    • 企業概要
    • 產品系列及說明
    • 主要亮點
    • 財務概要
  • Zoetis, Inc.
  • IDEXX Laboratories, Inc.
  • Virbac
  • Thermo Fisher Scientific, Inc.
  • Eurolyser Diagnostica GmbH
  • Woodley Equipment Company
  • Randox Laboratories LTD.
  • AniPOC, Ltd.
  • Carestream Health, Inc.

第13章 全球獸醫用照護現場診斷-DataM

  • 附錄
  • 關於本公司·服務
  • 諮詢方式
目錄
Product Code: DMVH4724

Market Overview

The global veterinary point-of-care diagnostics market size was valued at US$ XX million in 2021 and is estimated to reach US$ XX million by 2029, growing at a CAGR of XX % during the forecast period (2022-2028).

Analytical systems that provide clinically relevant information without a core diagnostic laboratory are used in point-of-care diagnostics. These tests are simplified versions of traditional laboratory assays intended to provide information at the point of use while allowing the individual practitioner significant autonomy.

Market Dynamics

The factors influencing the veterinary point-of-care diagnostics market are the increasing technological advancements. The growing demand for veterinary point-of-care diagnostics is expected to drive market growth.

The increasing technological advancements are expected to drive the market growth in the forecast period

Technological advancements have helped to improve the quality of human life and the lives of the animals that people care about. The field of veterinary medicine has advanced by leaps and bounds, allowing veterinarians to make faster diagnoses, more accurate prognoses, and ultimately save animal lives. Technology has also resulted in better care outcomes not only for pets but also for their owners. Rapid point-of-care tests in the veterinary clinic setting allow accurate insights derived from the results, giving clinicians more confidence in their prescribed treatment plans. Furthermore, the rapid nature of this type of testing allows for results to be produced in real-time, possibly while the patient is still in the hospital, removing the impact of time delays experienced with traditional reference laboratory testing methods. These breakthroughs are at the forefront of veterinary diagnostics. Heska, for instance, devotes its R&D budget to the development of new Analyzer and Diagnostics Platforms, the expansion of the menu of analyzer platforms, the upgrade of the cycle to already installed platforms, and other in-house inventions. Hence, the increasing adoption of new technological advancements and the development of new platforms is expected to drive market growth.

The challenges associated with veterinary point-of-care diagnostics is expected to hamper the market growth

Despite being promising and widely used in human and companion animal medicine, POC diagnostics in animal-product applications are limited. The primary reasons are cost-effectiveness and a lack of portability and simplicity. The majority of animal production operations make marginal profits and employ unskilled labor. The increased use of POC in production farms will necessitate the development of low-cost, simple-to-use devices and tests. Until now, the major manufacturers of POC devices and tests have not adequately addressed these challenges. Due to low-profit forecasts, technology companies are not always willing to share their technological advancements and collaborate with the farming sector. As a result, investments and interdisciplinary research in POC applications in livestock production are limited. Another major challenge in introducing new POC applications for monitoring animal health is farmers' inability to capitalize on new opportunities. Because of the initial investment cost, they are hesitant to invest in modern technologies and require extensive evidence before adopting a new product.

COVID-19 Impact Analysis

Government measures such as the issuance of stay-at-home guidelines and social distancing protocols during the first half of 2020 caused market participants to adjust, reduce, or suspend operating activities. Veterinary clinics and hospitals in various key geographies reported low patient volumes, with some directing resources solely to emergency cases. On the other hand, animal owners still provided veterinary care because it was widely regarded as an "essential" service. Stay-at-home policies reduced companion animal clinical visits, including the postponement of wellness visits and elective procedures, lowering demand for diagnostic testing services. During the second and third quarters of 2020, demand gradually recovered as governments relaxed stay-at-home policies. In addition, many companies reported intermittent delays in receiving supply during 2020 and an increase in shipping costs. Other challenges brought on by the COVID-19 pandemic included inefficiencies in remote collaboration and field testing.

Segment Analysis

Based on application, the Parasitology segment is expected to dominate the market growth

Parasitic infectious diseases are a major public health concern, particularly in developing countries where basic sanitation services are frequently inadequate. Diseases are exacerbated by environmental factors such as temperature, soil type, seasonal precipitation, and overall climate in each geographic region. The risk of infectious diseases transmitted through animals, carriers of more than 60 zoonotic agents, is growing in close proximity between people and animals, which is of great concern for public health.

These diseases, which are on the list of Neglected Tropical Diseases, cause losses in tropical and subtropical countries and temperate regions. Indeed, they affect over a billion people worldwide, a large proportion of whom are infected with one or more parasitic helminths, resulting in annual losses in the billions of dollars. Researchers have spent the last decade developing digital image processing models and pattern recognition techniques to detect parasite eggs in microscopic images. The main goal is to reduce human errors in fecal parasite diagnosis and to produce faster and more accurate results. These studies highlight the critical importance of automated identification of intestinal parasites in producing efficient and reliable results. Hence, many companies are launching POC diagnostics to detect intestinal parasites. For instance, on September 9th, 2020, Zoetis launched Vetscan Imagyst, a diagnostic platform that uses image recognition technology, algorithms, and cloud-based artificial intelligence (AI) to provide clinics with accurate testing results. Imagyst's initial application is to test faecal samples for parasites, but it can expand to other types of testing in the future. Imagyst was created to assist veterinarians in making accurate and timely point-of-care intestinal parasitic diagnoses for dogs and cats.

Geographical Analysis

North America region is expected to hold the largest market share in the global veterinary point-of-care diagnostics market

The growing adoption of companion animals and the rising expenditure on veterinary healthcare are expected to drive this region's market growth.

According to the American Pet Products Association (APPA), veterinary care is the second-highest source of spending in the pet care industry.

The annual industry-wide spending figures from the association show that money spent on veterinary care totaled $18.11 billion, outpacing growth in any other category by 6.1 percent. Figures for 2019 are expected to reach $18.98 billion, a 4.8 percent increase over last year's figures. According to the APPA, lower prices have likely increased the frequency of veterinary visits, making pet care more accessible to a broader customer base. In addition, the Society for the Prevention of Cruelty to Animals in Los Angeles reported that the adoption rate had more than doubled in June 2020, with daily adoptions ranging from 10 to 13 per day. In the long run, rising pet adoption may drive the growth of the veterinary point-of-care diagnostics market. The presence of major players such as Idexx Laboratories, Merck & Co. Inc, Zoetis Inc., and many other companies launching new products give the country an advantage in the global market.

Competitive Landscape

With mergers, acquisitions, and product launches, the global veterinary point-of-care diagnostics market is moderately competitive. Some of the key players in the market are Zoetis, Inc., IDEXX Laboratories, Inc., Heska Corporation, Virbac, Thermo Fisher Scientific, Inc., Eurolyser Diagnostica GmbH, Woodley Equipment Company, Randox Laboratories LTD., AniPOC, Ltd., Carestream Health, Inc. (a part of ONEX Corporation)

Heska Corporation

Overview: Heska Corporation develops, manufactures, and sells companion animal health products, primarily for dogs, cats, and horses. In the United States and Europe, the company also provides diagnostic and patient monitoring equipment and diagnostic laboratory products.

Product Portfolio: The company's product Element POC (epoc) provides results 35 seconds after the sample is introduced. All results are obtained from a single test card kept at room temperature. This is a significant advantage over other handhelds, cartridge-based technologies, which requires selecting which parameters one requires, or the more expensive alternative of running multiple consumables to get all of the parameters Element POC provides from a single test card.

Key Developments: On April 1st, 2020, Heska Corporation completed the acquisition of scil animal care company GmbH. With headquarters in Germany and operations in France, Italy, Spain, and Canada, scil has been a proven European leader in providing veterinary point-of-care laboratory and imaging diagnostics.

Why Purchase the Report?

  • Visualize the composition of the global veterinary point-of-care diagnostics market segmentation by product, by application, and end user highlighting the key commercial assets and players.
  • Identify commercial opportunities in global veterinary point-of-care diagnostics market by analyzing trends and co-development deals.
  • Excel data sheet with thousands of data points of global veterinary point-of-care diagnostics market- level 4/5 segmentation.
  • PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
  • Product mapping in excel for the key product of all major market players

The global veterinary point-of-care diagnostics market report would provide an access to an approx. 45+market data table, 40+figures and 180 pages.

Target Audience

  • Service Providers/ Buyers
  • Industry Investors/Investment Bankers
  • Education & Research Institutes
  • Research Professionals
  • Emerging Companies
  • Manufacturers

Market Segmentation

Global Veterinary Point-Of-Care Diagnostics Market- By Product

  • Consumables, Reagents, & Kits
  • Instruments & Devices

Global Veterinary Point-Of-Care Diagnostics Market-By Application

  • Parasitology
  • Diagnostic Imaging
  • Bacteriology
  • Virology
  • Cytology
  • Clinical Chemistry
  • Serology
  • Other

Global Veterinary Point-Of-Care Diagnostics Market- By End User

  • Veterinary Hospitals & Clinics
  • Home Care Settings
  • Other

Global Veterinary Point-Of-Care Diagnostics Market- By Region

  • North America
  • Europe
  • South America
  • Asia Pacific
  • Middle East and Africa

Table of Contents

1. Global Veterinary Point-Of-Care Diagnostics Market Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Global Veterinary Point-Of-Care Diagnostics Market- Market Definition and Overview

3. Global Veterinary Point-Of-Care Diagnostics Market- Executive Summary

  • 3.1. Market Snippet By Product
  • 3.2. Market Snippet By Application
  • 3.3. Market Snippet By End User
  • 3.4. Market Snippet By Region

4. Global Veterinary Point-Of-Care Diagnostics Market-Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers:
      • 4.1.1.1. The increasing technological advancements
    • 4.1.2. Restraints:
      • 4.1.2.1. The challenges associated with veterinary point-of-care diagnostics
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Global Veterinary Point-Of-Care Diagnostics Market- Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Unmet Needs

6. Global Veterinary Point-Of-Care Diagnostics Market- COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. Global Veterinary Point-Of-Care Diagnostics Market- By Product

  • 7.1. Introduction
  • 7.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
  • 7.3. Market Attractiveness Index, By Product
    • 7.3.1. Consumables, Reagents, & Kits
      • 7.3.1.1.1. Introduction
      • 7.3.1.1.2. Market Size Analysis, US$ Mn, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
    • 7.2.2. Instruments & Devices

8. Global Veterinary Point-Of-Care Diagnostics Market-By Application

  • 8.1. Introduction
  • 8.2. Market Size Analysis, and Y-o-Y Growth Analysis (%),By Application
  • 8.3. Market Attractiveness Index,By Application
    • 8.3.2. Parasitology
      • 8.3.2.1.1. Introduction
      • 8.3.2.1.2. Market Size Analysis, US$ Mn, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
    • 8.3.3. Diagnostic Imaging
    • 8.3.4. Bacteriology
    • 8.3.5. Virology
    • 8.3.6. Cytology
    • 8.3.7. Clinical Chemistry
    • 8.3.8. Serology
    • 8.3.9. Other

9. Global Veterinary Point-Of-Care Diagnostics Market- By End User

  • 9.1. Introduction
    • 9.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 9.1.3. Market Attractiveness Index, By End User
  • 9.2. Veterinary Hospitals & Clinics*
    • 9.2.2. Introduction
    • 9.2.3. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. Home Care Settings
  • 9.4. Other

10. Global Veterinary Point-Of-Care Diagnostics Market- By Region

  • 10.1. Introduction
    • 10.1.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 10.1.3. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.2. Introduction
    • 10.2.3. Key Region-Specific Dynamics Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 10.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%),By Application
    • 10.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.2. Introduction
    • 10.3.3. Key Region-Specific Dynamics
    • 10.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 10.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%),By Application
    • 10.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.3.7.1. Germany
      • 10.3.7.2. U.K.
      • 10.3.7.3. France
      • 10.3.7.4. Italy
      • 10.3.7.5. Spain
      • 10.3.7.6. Rest of Europe
  • 10.4. South America
    • 10.4.2. Introduction
    • 10.4.3. Key Region-Specific Dynamics Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%),By Application
    • 10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia Pacific
    • 10.5.2. Introduction
    • 10.5.3. Key Region-Specific Dynamics Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%),By Application
    • 10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia Pacific
  • 10.6. Middle East and Africa
    • 10.6.2. Introduction
    • 10.6.3. Key Region-Specific Dynamics Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%),By Application
    • 10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User

11. Global Veterinary Point-Of-Care Diagnostics Market- Competitive Landscape

  • 11.1. Key Developments and Strategies
  • 11.2. Company Share Analysis
  • 11.3. Product Benchmarking

12. Global Veterinary Point-Of-Care Diagnostics Market- Company Profiles

  • 12.1. Heska Corporation*
    • 12.1.2. Company Overview
    • 12.1.3. Product Portfolio and Description
    • 12.1.4. Key Highlights
    • 12.1.5. Financial Overview
  • 12.2. Zoetis, Inc.
  • 12.3. IDEXX Laboratories, Inc.
  • 12.4. Virbac
  • 12.5. Thermo Fisher Scientific, Inc.
  • 12.6. Eurolyser Diagnostica GmbH
  • 12.7. Woodley Equipment Company
  • 12.8. Randox Laboratories LTD.
  • 12.9. AniPOC, Ltd.
  • 12.10. Carestream Health, Inc.

LIST NOT EXHAUSTIVE

13. Global Veterinary Point-Of-Care Diagnostics Market- DataM

    • 13.1.2. Appendix
    • 13.1.3. About Us and Services
    • 13.1.4. Contact Us